As Congress considers a bill that aims to distance U.S. biopharma from five Chinese companies, the industry must emphasize the importance of prioritizing patient care over power plays.
BIOSECURE Act Threatens Already Strained U.S. Supply Chain Read More »
The next generation of Alzheimer’s therapeutics is moving away from amyloid plaques and tau tangles, offering multiple approaches to slow cognitive decline.
Late-Stage Alzheimer’s Pipeline Goes Beyond Amyloid and Tau Read More »
Bringing drugs to market is notoriously time-consuming and expensive. Small companies are uniquely positioned to change that.
Small Biopharma Is Bringing AI Efficiency to Clinical Trials Read More »
La evolución de la tecnología móvil ha dado lugar a importantes mejoras en la conectividad. Las diferencias entre 4G y 5G incluyen la velocidad, la latencia y la calidad de conexión, con 5G ofreciendo velocidades significativamente más rápidas y un …
Cuáles son las diferencias entre 4g y 5g: Evolución de la conectividad móvil Read More »
A new, more holistic approach to testing is needed to avoid mistakes that can cause harm, said Marcus Schabacker, CEO of the patient safety group ECRI.
Diagnostic errors are common. Here are 4 ways to prevent them Read More »
Johnson & Johnson did not provide Auris Health with resources to achieve regulatory milestones after acquiring the robotics company in 2019, the judge found.
Judge orders J&J to pay Auris investors more than $1B for merger violations Read More »
Federal antitrust regulators are asking Indiana to block Union Hospital and HCA-owned Terre Haute Regional Hospital’s request for a certificate of public advantage, which allows states to greenlight potentially problematic mergers.
FTC opposes Indiana’s first hospital merger under controversial COPA law Read More »
The new company, which doesn’t yet have a formal name, will be led by David Pierre, previously the chief operating officer of home healthcare company Signify Health.
New Mountain merges Rawlings, Varis, Apixio assets to form payment accuracy firm Read More »
Priced at $49 for one 14-day sensor, or $89 per month, Abbott’s offering is competitive with Dexcom’s Stelo sensor.
Abbott debuts Lingo over-the-counter CGM in the US Read More »
Astellas Pharma’s new life sciences center houses its first U.S.-based SakuLab, an incubator space for external partners, as well as its engineered small molecules unit.
Astellas Pharma Opens Cambridge Life Sciences Center Featuring Incubator Space Read More »
